These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27821312)
21. Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population. Dingemans SA; de Rooij PD; van der Vuurst de Vries RM; Budel LM; Contant CM; van der Pool AE Ann Surg Oncol; 2016 Feb; 23(2):477-81. PubMed ID: 26369528 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience. Somali I; Ustaoglu BY; Tarhan MO; Yigit SC; Demir L; Ellidokuz H; Erten C; Alacacioglu A Asian Pac J Cancer Prev; 2013; 14(10):6013-7. PubMed ID: 24289617 [TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy in breast cancers. Masood S Womens Health (Lond); 2016 Sep; 12(5):480-491. PubMed ID: 27885165 [TBL] [Abstract][Full Text] [Related]
24. Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrence. Ishitobi M; Okumura Y; Arima N; Yoshida A; Nakatsukasa K; Iwase T; Shien T; Masuda N; Tanaka S; Tanabe M; Tanaka T; Komoike Y; Taguchi T; Nishimura R; Inaji H Ann Surg Oncol; 2013 Jun; 20(6):1886-92. PubMed ID: 23292516 [TBL] [Abstract][Full Text] [Related]
25. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [TBL] [Abstract][Full Text] [Related]
26. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study. Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981 [TBL] [Abstract][Full Text] [Related]
27. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases. Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218 [TBL] [Abstract][Full Text] [Related]
28. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast. Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636 [TBL] [Abstract][Full Text] [Related]
29. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients. Szollár A; Újhelyi M; Polgár C; Oláh E; Pukancsik D; Rubovszky G; Udvarhelyi N; Kovács T; Sávolt Á; Kenessey I; Mátrai Z Eur J Surg Oncol; 2019 Nov; 45(11):2009-2015. PubMed ID: 31189512 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355 [TBL] [Abstract][Full Text] [Related]
31. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys. Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735 [TBL] [Abstract][Full Text] [Related]
32. Triple-negative breast cancers: unique clinical presentations and outcomes. Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062 [TBL] [Abstract][Full Text] [Related]
33. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran. Amirifard N; Sadeghi E Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer]. Wang YJ; Wang N; Wang B; Qin WX; Xue CY Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082 [TBL] [Abstract][Full Text] [Related]
35. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications]. Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020 [TBL] [Abstract][Full Text] [Related]
36. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916 [TBL] [Abstract][Full Text] [Related]
37. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer. Torrisi R; Bagnardi V; Rotmensz N; Scarano E; Iorfida M; Veronesi P; Luini A; Viale G; Santoro A; Colleoni M; Goldhirsch A Breast Cancer Res Treat; 2011 Apr; 126(2):431-41. PubMed ID: 21221766 [TBL] [Abstract][Full Text] [Related]
38. Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer. Grewal J; Zhou H; Factor R; Kesari S J Clin Oncol; 2010 May; 28(13):e200-2. PubMed ID: 20124173 [No Abstract] [Full Text] [Related]
39. Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Wei S; Li Y; Siegal GP; Hameed O Ann Diagn Pathol; 2011 Apr; 15(2):79-83. PubMed ID: 21163679 [TBL] [Abstract][Full Text] [Related]
40. Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. Cortadellas T; Córdoba O; Gascón A; Haladjian C; Bernabeu A; Alcalde A; Esgueva A; Rodriguez-Revuelto R; Espinosa-Bravo M; Díaz-Botero S; Xercavins J; Rubio IT; Gil-Moreno A Eur J Surg Oncol; 2015 May; 41(5):635-40. PubMed ID: 25703077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]